These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11422598)

  • 21. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
    Haria M; Bryson HM; Goa KL
    Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of itraconazole].
    Cauwenbergh G
    Mycoses; 1994; 37 Suppl 2():27-33. PubMed ID: 7609740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Itraconazole oral solution: pharmacokinetics and absorption.
    Saag M
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S16-7. PubMed ID: 11361746
    [No Abstract]   [Full Text] [Related]  

  • 24. Population pharmacokinetics of itraconazole in Japanese patients with invasive fungal peritonitis.
    Yamagishi Y; Hamada Y; Hagihara M; Mikamo H
    Jpn J Antibiot; 2013 Jun; 66(3):159-68. PubMed ID: 24167844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
    de Repentigny L; Ratelle J; Leclerc JM; Cornu G; Sokal EM; Jacqmin P; De Beule K
    Antimicrob Agents Chemother; 1998 Feb; 42(2):404-8. PubMed ID: 9527794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.
    Lestner J; Hope WW
    Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):911-26. PubMed ID: 23641752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
    Otani H; Inoue K; Shiota T; Suzuki Y; Nomura S; Harada Y; Ishibashi H; Abe S; Uchida K; Yamaguchi H; Torii S
    Nihon Yakurigaku Zasshi; 2007 Jul; 130(1):69-76. PubMed ID: 17634684
    [No Abstract]   [Full Text] [Related]  

  • 29. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.
    Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
    Pharmacotherapy; 1998; 18(2):295-301. PubMed ID: 9545149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on azole antifungals.
    Zonios DI; Bennett JE
    Semin Respir Crit Care Med; 2008 Apr; 29(2):198-210. PubMed ID: 18366001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
    Abdel-Rahman SM; Jacobs RF; Massarella J; Kauffman RE; Bradley JS; Kimko HC; Kearns GL; Shalayda K; Curtin C; Maldonado SD; Blumer JL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2668-73. PubMed ID: 17517842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection.
    Uchida K; Shimogawara K; Yamaguchi H
    J Antimicrob Chemother; 2011 Mar; 66(3):626-34. PubMed ID: 21172782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of compounding on pharmacokinetics of itraconazole in black-footed penguins (Spheniscus demersus).
    Smith JA; Papich MG; Russell G; Mitchell MA
    J Zoo Wildl Med; 2010 Sep; 41(3):487-95. PubMed ID: 20945648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A brief review of antifungal therapy for deep fungal infection.
    Muller RJ
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
    Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European experience with oral solution and intravenous itraconazole.
    Potter M
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of itraconazole in haematology/oncology.
    Pandya NA; Atra AA; Riley U; Pinkerton CR
    Arch Dis Child; 2003 Mar; 88(3):258-60. PubMed ID: 12598396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
    Vandewoude K; Vogelaers D; Decruyenaere J; Jaqmin P; De Beule K; Van Peer A; Woestenborghs R; Groen K; Colardyn F
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2714-8. PubMed ID: 9420044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
    Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of absorption characteristics of oral reference and compounded itraconazole formulations in healthy cats.
    Mawby DI; Whittemore JC; Fowler LE; Papich MG
    J Am Vet Med Assoc; 2018 Jan; 252(2):195-200. PubMed ID: 29319446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.